MTIM
CELG

Marathon Trading Investment Management’s Celgene Corp CELG Stock Holding History

Marathon Trading Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-102,000
Closed -$9.62M – 316
2019
Q1 		$9.62M Buy
+102,000
New +$8.92M 1.13% 21
2017
Q3 		– Sell
-37,000
Closed -$4.8M – 191
2017
Q2 		$4.8M Buy
+37,000
New +$4.53M 0.89% 28
2015
Q1 		– Sell
-6,200
Closed -$693K – 707
2014
Q4 		$693K Hold
6,200
– – 0.01% 378
2014
Q3 		$588K Sell
6,200
-2,000
-24% -$180K 0.02% 196
2014
Q2 		$704K Sell
8,200
-4,000
-33% -$304K 0.02% 186
2014
Q1 		$426K Buy
+12,200
New +$966K 0.02% 187

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Marathon Trading Investment Management's CELG Position: Q4 2019 in Review

Marathon Trading Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,000 shares — an estimated $397K sold.

Marathon Trading Investment Management first reported a position in CELG in Q4 2014 and held it in 4 quarters. The position peaked at $1.25M in Q4 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Marathon Trading Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Marathon Trading Investment Management sold 4,000 Celgene Corp shares in Q4 2019, an estimated $397K.
  • Marathon Trading Investment Management first reported a position in Celgene Corp in Q4 2014 and held it in 4 quarters.
  • Marathon Trading Investment Management's Celgene Corp position peaked at $1.25M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Marathon Trading Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.